Published in

Royal Society of Chemistry, RSC Medicinal Chemistry, 2(11), p. 164-183, 2020

DOI: 10.1039/c9md00447e

Links

Tools

Export citation

Search in Google Scholar

Small molecule inhibitors in pancreatic cancer

Journal article published in 2020 by Jufeng Sun ORCID, Cecilia C. Russell ORCID, Christopher J. Scarlett ORCID, Adam McCluskey ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Pancreatic cancer (PC), with a 5-year survival of <7%, is one of the most fatal of all human cancers. There is an urgent need to develop more effective therapies to move beyond the current dire condition and paucity of PC treatment options.